PTC Therapeutics, Inc. (PTCT)
USD 45.08
(4.89%)
USD 45.08
(4.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -626.6 Million USD | -12.09% |
| 2022 | -559.01 Million USD | -6.7% |
| 2021 | -523.9 Million USD | -19.57% |
| 2020 | -438.16 Million USD | -74.17% |
| 2019 | -251.57 Million USD | -96.42% |
| 2018 | -128.08 Million USD | -62.13% |
| 2017 | -79 Million USD | 44.41% |
| 2016 | -142.11 Million USD | 16.63% |
| 2015 | -170.44 Million USD | -81.8% |
| 2014 | -93.75 Million USD | -81.78% |
| 2013 | -51.57 Million USD | -96.58% |
| 2012 | -26.23 Million USD | -184.89% |
| 2011 | 30.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -99.17 Million USD | -8.3% |
| 2024 Q1 | -91.57 Million USD | 41.22% |
| 2023 FY | -626.6 Million USD | -12.09% |
| 2023 Q4 | -155.79 Million USD | -17.16% |
| 2023 Q1 | -138.95 Million USD | 18.68% |
| 2023 Q3 | -132.97 Million USD | 33.14% |
| 2023 Q2 | -198.88 Million USD | -43.12% |
| 2022 Q2 | -152.08 Million USD | -20.01% |
| 2022 Q3 | -109.31 Million USD | 28.12% |
| 2022 Q4 | -170.88 Million USD | -56.33% |
| 2022 FY | -559.01 Million USD | -6.7% |
| 2022 Q1 | -126.72 Million USD | 11.54% |
| 2021 FY | -523.9 Million USD | -19.57% |
| 2021 Q4 | -143.26 Million USD | -7.22% |
| 2021 Q3 | -133.62 Million USD | -12.89% |
| 2021 Q2 | -118.37 Million USD | 7.98% |
| 2021 Q1 | -128.64 Million USD | -73.01% |
| 2020 Q2 | -181.42 Million USD | -61.0% |
| 2020 FY | -438.16 Million USD | -74.17% |
| 2020 Q1 | -112.68 Million USD | -45.07% |
| 2020 Q3 | -69.69 Million USD | 61.59% |
| 2020 Q4 | -74.35 Million USD | -6.69% |
| 2019 Q2 | -41.78 Million USD | 42.05% |
| 2019 Q3 | -59.99 Million USD | -43.57% |
| 2019 FY | -251.57 Million USD | -96.42% |
| 2019 Q1 | -72.11 Million USD | -49.21% |
| 2019 Q4 | -77.67 Million USD | -29.47% |
| 2018 Q3 | -50.96 Million USD | -435.39% |
| 2018 Q4 | -48.33 Million USD | 5.18% |
| 2018 FY | -128.08 Million USD | -62.13% |
| 2018 Q2 | -9.52 Million USD | 50.58% |
| 2018 Q1 | -19.26 Million USD | -1616.77% |
| 2017 Q4 | 1.27 Million USD | 103.76% |
| 2017 FY | -79 Million USD | 44.41% |
| 2017 Q1 | -29.05 Million USD | -8.44% |
| 2017 Q2 | -17.47 Million USD | 39.86% |
| 2017 Q3 | -33.73 Million USD | -93.06% |
| 2016 Q1 | -41.23 Million USD | 19.07% |
| 2016 FY | -142.11 Million USD | 16.63% |
| 2016 Q3 | -35.16 Million USD | 9.63% |
| 2016 Q4 | -26.79 Million USD | 23.8% |
| 2016 Q2 | -38.91 Million USD | 5.62% |
| 2015 FY | -170.44 Million USD | -81.8% |
| 2015 Q4 | -50.94 Million USD | -17.87% |
| 2015 Q3 | -43.22 Million USD | -12.67% |
| 2015 Q2 | -38.36 Million USD | -1.18% |
| 2015 Q1 | -37.91 Million USD | -39.04% |
| 2014 Q1 | -14.09 Million USD | 21.18% |
| 2014 FY | -93.75 Million USD | -81.78% |
| 2014 Q3 | -27.28 Million USD | -8.68% |
| 2014 Q4 | -27.26 Million USD | 0.05% |
| 2014 Q2 | -25.1 Million USD | -78.07% |
| 2013 Q3 | -4.41 Million USD | 69.72% |
| 2013 Q4 | -17.88 Million USD | -304.98% |
| 2013 FY | -51.57 Million USD | -96.58% |
| 2013 Q1 | -14.68 Million USD | -134.13% |
| 2013 Q2 | -14.58 Million USD | 0.67% |
| 2012 Q1 | -6.59 Million USD | 0.0% |
| 2012 FY | -26.23 Million USD | -184.89% |
| 2012 Q3 | -7.29 Million USD | -20.25% |
| 2012 Q4 | -6.27 Million USD | 14.05% |
| 2012 Q2 | -6.06 Million USD | 8.03% |
| 2011 FY | 30.9 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agenus Inc. | -245.76 Million USD | -154.965% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3961.987% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -309.567% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -513.896% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -67.707% |
| MiMedx Group, Inc. | 67.43 Million USD | 1029.142% |
| Novavax, Inc. | -545.06 Million USD | -14.96% |
| Seer, Inc. | -86.27 Million USD | -626.27% |
| Acelyrin, Inc. | -381.64 Million USD | -64.187% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -906.512% |
| IO Biotech, Inc. | -86.08 Million USD | -627.907% |
| Ardelyx, Inc. | -66.06 Million USD | -848.437% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -372.934% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1304.837% |
| Fortress Biotech, Inc. | -60.63 Million USD | -933.369% |
| Fortress Biotech, Inc. | -60.63 Million USD | -933.369% |
| Geron Corporation | -184.12 Million USD | -240.311% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -205.251% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -668.085% |
| Incyte Corporation | 597.59 Million USD | 204.854% |
| Innoviva, Inc. | 179.72 Million USD | 448.652% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7270.945% |
| ChromaDex Corporation | -4.93 Million USD | -12589.429% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1301.45% |
| MEI Pharma, Inc. | 17.77 Million USD | 3624.603% |
| NextCure, Inc. | -62.72 Million USD | -899.002% |
| Onconetix, Inc. | -37.4 Million USD | -1574.978% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1487.183% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1598.141% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -454.708% |
| Vaxcyte, Inc. | -402.26 Million USD | -55.769% |
| Precigen, Inc. | -95.9 Million USD | -553.366% |
| Pharming Group N.V. | -10.54 Million USD | -5840.501% |
| ContextLogic Inc. | -317 Million USD | -97.667% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -17363.88% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -749.172% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2397.326% |
| AlloVir, Inc. | -190.41 Million USD | -229.068% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2474.455% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -343.127% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4995670.445% |
| Summit Therapeutics Inc. | -614.92 Million USD | -1.899% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -199.295% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1737.495% |
| Senti Biosciences, Inc. | -92.91 Million USD | -574.355% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -249.954% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1683.164% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -9273.283% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1124.816% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -962.353% |
| Chimerix, Inc. | -82.09 Million USD | -663.267% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1359.18% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2988.088% |
| CRISPR Therapeutics AG | -153.61 Million USD | -307.919% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -989.5% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -210.828% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2453.086% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -538.434% |
| Precision BioSciences, Inc. | -61.31 Million USD | -921.876% |
| Dyadic International, Inc. | -6.79 Million USD | -9120.92% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1271.005% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -66844.872% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1106.748% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -42.332% |
| Aptorum Group Limited | -2.82 Million USD | -22083.445% |
| Bicycle Therapeutics plc | -180.66 Million USD | -246.834% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4693.532% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1828.903% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3192.91% |
| GT Biopharma, Inc. | -7.59 Million USD | -8148.045% |
| Alkermes plc | 355.75 Million USD | 276.133% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -835.3% |
| Jaguar Health, Inc. | -41.3 Million USD | -1417.201% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -2034.064% |
| AbCellera Biologics Inc. | -146.39 Million USD | -328.014% |
| PureTech Health plc | -65.69 Million USD | -853.779% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3278.63% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -143.029% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1578.104% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -754.301% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2474.455% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -852.793% |
| AnaptysBio, Inc. | -163.61 Million USD | -282.965% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1649.753% |
| ESSA Pharma Inc. | -26.58 Million USD | -2257.219% |
| Molecular Templates, Inc. | -8.12 Million USD | -7612.999% |
| Scopus BioPharma Inc. | -11.6 Million USD | -5297.186% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -9.385% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1100479.619% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1127.24% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2200.477% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -974.922% |
| Structure Therapeutics Inc. | -89.62 Million USD | -599.179% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1051.38% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -498.481% |
| ImmuCell Corporation | -5.77 Million USD | -10751.041% |
| Lantern Pharma Inc. | -15.96 Million USD | -3825.713% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2102.32% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -6174.825% |
| Opthea Limited | -220.24 Million USD | -184.507% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -195.262% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -280.743% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -289.369% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -159.613% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 977.474% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1175.66% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -6198.955% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -155.137% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1123.669% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -537.454% |
| Soligenix, Inc. | -6.14 Million USD | -10104.064% |
| Century Therapeutics, Inc. | -136.67 Million USD | -358.469% |
| Kura Oncology, Inc. | -152.63 Million USD | -310.535% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -602.329% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5846.138% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 110911.184% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -110023.726% |
| Autolus Therapeutics plc | -208.38 Million USD | -200.698% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -771.518% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -785.096% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2791.841% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -178.182% |
| GRI Bio, Inc. | -13.03 Million USD | -4706.351% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -15055.211% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -404.984% |
| IGM Biosciences, Inc. | -246.41 Million USD | -154.287% |
| INmune Bio, Inc. | -30 Million USD | -1988.123% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -466.76% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1385.062% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3825.682% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3867.108% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -949.852% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -519.376% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -126.927% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -163.399% |
| Verastem, Inc. | -87.36 Million USD | -617.209% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1056.352% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -288.384% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -437.129% |
| Histogen Inc. | -10.62 Million USD | -5799.67% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -4285.908% |
| Surrozen, Inc. | -43.04 Million USD | -1355.797% |
| Organovo Holdings, Inc. | -14.67 Million USD | -4171.038% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -12217.681% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1097.204% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2380.323% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2226.097% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -7397.877% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -314.736% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1180.717% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -2008.003% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5914.799% |
| Apollomics, Inc. | -172.6 Million USD | -263.036% |
| Amarin Corporation plc | -59.11 Million USD | -960.028% |
| Mesoblast Limited | -87.95 Million USD | -612.406% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1035.152% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -326.371% |
| Synaptogenix, Inc. | -6.03 Million USD | -10276.809% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3766.017% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -703.133% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12977.501% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -7357.622% |
| Exelixis, Inc. | 207.76 Million USD | 401.593% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1475.966% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -335.299% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -18.534% |
| NLS Pharmaceutics AG | -12.17 Million USD | -5047.901% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7938.857% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1937.803% |
| Gritstone bio, Inc. | -138.49 Million USD | -352.454% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -872.007% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -15565.296% |
| Avid Bioservices, Inc. | -140.75 Million USD | -345.18% |
| Insmed Incorporated | -749.56 Million USD | 16.405% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -4025.242% |
| MediWound Ltd. | -6.71 Million USD | -9230.018% |
| OmniAb, Inc. | -50.61 Million USD | -1137.883% |
| Alector, Inc. | -130.39 Million USD | -380.558% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -450.987% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1108.564% |
| Zai Lab Limited | -334.62 Million USD | -87.258% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -93.405% |
| Aura Biosciences, Inc. | -76.4 Million USD | -720.076% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -167.058% |
| Immunic, Inc. | -93.61 Million USD | -569.363% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -361.101% |
| Veracyte, Inc. | -74.4 Million USD | -742.164% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -8063.636% |
| FibroGen, Inc. | -284.23 Million USD | -120.455% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2288.701% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8849.069% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3227.214% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 251.05% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2678.116% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1371.75% |
| TG Therapeutics, Inc. | 12.67 Million USD | 5044.792% |
| Galecto, Inc. | -38.34 Million USD | -1533.951% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3221.34% |
| Fortrea Holdings Inc. | -3.4 Million USD | -18329.529% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -394.776% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3498.897% |
| XBiotech Inc. | -24.55 Million USD | -2451.631% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -872.007% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -899.687% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -536.624% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2824.366% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1035.296% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -3.291% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -818.034% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -176.599% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2713.982% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -185.196% |
| NexImmune, Inc. | -32.34 Million USD | -1837.288% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -11752.742% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4361.118% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 115.849% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2487.028% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -436.485% |
| Ainos, Inc. | -13.77 Million USD | -4450.32% |
| Pluri Inc. | -20.88 Million USD | -2899.828% |
| Prothena Corporation plc | -147.02 Million USD | -326.18% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -450.275% |
| Celularity Inc. | -196.29 Million USD | -219.215% |
| Rallybio Corporation | -74.56 Million USD | -740.357% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1135.101% |
| MeiraGTx Holdings plc | -84.02 Million USD | -645.717% |
| Omeros Corporation | -117.81 Million USD | -431.863% |
| Humacyte, Inc. | -110.77 Million USD | -465.65% |
| Immunocore Holdings plc | -55.28 Million USD | -1033.366% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3384.23% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2632.563% |
| Blueprint Medicines Corporation | -506.98 Million USD | -23.594% |
| CalciMedica, Inc. | -34.35 Million USD | -1723.803% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -825.902% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -277.953% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -121.216% |
| Pulmatrix, Inc. | -14.12 Million USD | -4337.391% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1680.378% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -658.252% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -30.219% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -497.5% |
| Cytokinetics, Incorporated | -526.24 Million USD | -19.071% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1637.43% |
| Nutriband Inc. | -5.48 Million USD | -11323.302% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1450.233% |
| Vor Biopharma Inc. | -117.86 Million USD | -431.638% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 114.408% |
| Evogene Ltd. | -23.87 Million USD | -2524.08% |
| ProKidney Corp. | -35.46 Million USD | -1666.674% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -423.203% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7886.907% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 2.581% |
| CorMedix Inc. | -46.33 Million USD | -1252.211% |
| BioLineRx Ltd. | -60.61 Million USD | -933.761% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -515.863% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1425.846% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1457.786% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -676.941% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -729.708% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -114.45% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2147.826% |
| MediciNova, Inc. | -8.57 Million USD | -7210.305% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -408.289% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7380.201% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2313.1% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -161.917% |
| Biomea Fusion, Inc. | -117.25 Million USD | -434.394% |
| Mereo BioPharma Group plc | -29.46 Million USD | -2026.532% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -309.112% |
| Absci Corporation | -110.56 Million USD | -466.724% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1978.289% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -521.403% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -165.581% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4549.049% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -224.729% |
| Allakos Inc. | -185.7 Million USD | -237.426% |
| Imunon, Inc. | -19.51 Million USD | -3110.888% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -543.76% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 690.356% |
| BioAtla, Inc. | -123.46 Million USD | -407.528% |
| NLS Pharmaceutics AG | -12.17 Million USD | -5047.901% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3797.276% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -91.467% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1595.862% |
| XOMA Corporation | -40.83 Million USD | -1434.628% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -515.102% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -428.722% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1143.533% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -614.657% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -312.894% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -163.574% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1684.231% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7643.557% |
| Akari Therapeutics, Plc | -10 Million USD | -6161.031% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -930615.188% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 322.52% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9301.553% |
| UroGen Pharma Ltd. | -102.24 Million USD | -512.852% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -486.746% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7956.952% |
| Orgenesis Inc. | -55.36 Million USD | -1031.851% |
| Entera Bio Ltd. | -8.88 Million USD | -6949.207% |
| GH Research PLC | -35.58 Million USD | -1660.767% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2906.737% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -709.691% |
| Xencor, Inc. | -126.08 Million USD | -396.962% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -16539.766% |
| Replimune Group, Inc. | -215.79 Million USD | -190.371% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2846.432% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 25074.253% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9301.553% |
| Portage Biotech Inc. | -75.33 Million USD | -731.713% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7380.201% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -548.289% |
| OncoCyte Corporation | -27.78 Million USD | -2155.513% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4570.151% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5534.158% |
| Purple Biotech Ltd. | -19.88 Million USD | -3051.932% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8827.255% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1043.229% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3479.338% |
| HilleVax, Inc. | -123.56 Million USD | -407.101% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -6099.703% |
| Tharimmune, Inc. | -9.31 Million USD | -6623.873% |
| Genprex, Inc. | -30.86 Million USD | -1930.443% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -165.595% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1982.156% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -35062.963% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -11731.613% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3724041.866% |
| Savara Inc. | -54.69 Million USD | -1045.57% |
| Curis, Inc. | -47.41 Million USD | -1221.587% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1977.504% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3956.979% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -11151.643% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -2001.64% |
| BeiGene, Ltd. | -881.7 Million USD | 28.933% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2842.632% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -43.596% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -693.622% |
| Erasca, Inc. | -125.04 Million USD | -401.115% |
| bluebird bio, Inc. | -211.91 Million USD | -195.689% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12430.834% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 473.768% |
| DBV Technologies S.A. | -72.72 Million USD | -761.596% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12430.834% |
| Moderna, Inc. | -4.71 Billion USD | 86.708% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1460.385% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -10904.636% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -937.63% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -462.486% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -362.944% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1207.632% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -343.052% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -225.661% |
| MacroGenics, Inc. | -9.05 Million USD | -6817.686% |
| RenovoRx, Inc. | -10.23 Million USD | -6023.964% |
| Adicet Bio, Inc. | -142.65 Million USD | -339.235% |
| Prime Medicine, Inc. | -198.13 Million USD | -216.254% |
| Aditxt, Inc. | -32.38 Million USD | -1835.107% |
| Adagene Inc. | -18.94 Million USD | -3207.251% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8469.854% |
| Quantum-Si incorporated | -95.96 Million USD | -552.985% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -426.43% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4198.353% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 573.516% |
| SciSparc Ltd. | -5.12 Million USD | -12133.581% |
| Vericel Corporation | -3.18 Million USD | -19592.143% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -520967.075% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1988.307% |
| Generation Bio Co. | -126.61 Million USD | -394.901% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -759.645% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -660.054% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -139.034% |
| Invivyd, Inc. | -198.64 Million USD | -215.442% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -83.232% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -7113.478% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2847.54% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -6246.0% |
| 2seventy bio, Inc. | -217.57 Million USD | -188.001% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2118.931% |
| Clene Inc. | -49.5 Million USD | -1165.764% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2711.454% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1167.557% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2313.1% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -90.999% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1825.47% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2857.94% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -534.268% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -738.221% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -289.667% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -1.877% |
| Evaxion Biotech A/S | -22.12 Million USD | -2732.108% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -676.115% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -213.196% |
| Trevena, Inc. | -40.28 Million USD | -1455.273% |
| Surrozen, Inc. | -43.04 Million USD | -1355.797% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -806.362% |
| Cingulate Inc. | -23.53 Million USD | -2562.441% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8965.451% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1472.012% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -8026.45% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -594.606% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -922.426% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -953.063% |
| Clearmind Medicine Inc. | -11.95 Million USD | -5141.341% |
| Kronos Bio, Inc. | -112.67 Million USD | -456.126% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -805.536% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24706018.925% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -629.5% |
| Statera Biopharma, Inc. | -174.4 Million USD | -259.274% |
| ImmunityBio, Inc. | -583.19 Million USD | -7.443% |
| Korro Bio, Inc. | -81.17 Million USD | -671.946% |
| Kineta, Inc. | -14.09 Million USD | -4344.315% |
| BioVie Inc. | -32.12 Million USD | -1850.79% |
| Codexis, Inc. | -76.24 Million USD | -721.884% |
| Celularity Inc. | -196.29 Million USD | -219.215% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -192.084% |
| Celcuity Inc. | -63.77 Million USD | -882.46% |
| Virax Biolabs Group Limited | -6.73 Million USD | -9205.719% |
| Cibus, Inc. | -267.62 Million USD | -134.133% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1453.846% |
| IN8bio, Inc. | -30 Million USD | -1988.193% |
| Kodiak Sciences Inc. | -260.49 Million USD | -140.547% |
| Annexon, Inc. | -134.23 Million USD | -366.789% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -434.805% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -923.395% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1886.444% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -71.07% |
| Eyenovia, Inc. | -27.26 Million USD | -2198.528% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 3002.154% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -117022.243% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -720.119% |
| Arcellx, Inc. | -70.69 Million USD | -786.411% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1412.039% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -368.258% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1986.107% |
| Moolec Science SA | -51.78 Million USD | -1109.92% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1096.471% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1392.838% |
| Royalty Pharma plc | 1.13 Billion USD | 155.215% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -360.887% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6946.985% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2849.664% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -265.005% |
| Humacyte, Inc. | -110.77 Million USD | -465.65% |
| 89bio, Inc. | -142.18 Million USD | -340.684% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -808.648% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5938.393% |
| Genelux Corporation | -28.29 Million USD | -2114.383% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2055.871% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -253.776% |
| Notable Labs, Ltd. | -11.26 Million USD | -5462.891% |
| Liquidia Corporation | -78.5 Million USD | -698.201% |
| Mustang Bio, Inc. | -51.6 Million USD | -1114.302% |
| Immunovant, Inc. | -259.33 Million USD | -141.619% |
| Quantum-Si incorporated | -95.96 Million USD | -552.985% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -760.141% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3133.084% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -552.78% |
| Acasti Pharma Inc. | -12.85 Million USD | -4775.158% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2690.132% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3825.682% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -243.546% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -14467.047% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4924.892% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -2024.73% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1507.171% |
| PepGen Inc. | -78.62 Million USD | -696.942% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -2004.888% |
| United Therapeutics Corporation | 984.8 Million USD | 163.628% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2714.933% |
| Solid Biosciences Inc. | -96.01 Million USD | -552.611% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12977.501% |
| Immuneering Corporation | -53.47 Million USD | -1071.844% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -12217.681% |
| Silo Pharma, Inc. | -3.7 Million USD | -16832.118% |
| Belite Bio, Inc | -31.63 Million USD | -1880.918% |
| XOMA Corporation | -40.83 Million USD | -1434.628% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1052.587% |
| Bionomics Limited | -15.49 Billion USD | 95.955% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -646.09% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2049.069% |
| uniQure N.V. | -308.47 Million USD | -103.128% |
| Cassava Sciences, Inc. | -97.21 Million USD | -544.542% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8469.854% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -407.659% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1890.736% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7539.926% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2055.649% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -117022.243% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2288.701% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3701.056% |
| Altimmune, Inc. | -88.44 Million USD | -608.451% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -313.371% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2049.069% |
| Compugen Ltd. | -18.75 Million USD | -3241.175% |
| Peak Bio, Inc. | -1259.26 USD | -49759600.141% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1260.733% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2780.805% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -84.954% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -655.363% |
| Zura Bio Limited | -60.36 Million USD | -938.111% |
| PolyPid Ltd. | -23.86 Million USD | -2525.619% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3882.99% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -655.363% |
| Instil Bio, Inc. | -156.08 Million USD | -301.445% |
| argenx SE | -295.05 Million USD | -112.37% |
| Immunome, Inc. | -106.8 Million USD | -486.675% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1374.571% |
| Verona Pharma plc | -54.36 Million USD | -1052.502% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -527.125% |
| Shattuck Labs, Inc. | -87.29 Million USD | -617.776% |
| CervoMed Inc. | -2.17 Million USD | -28750.858% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -402.687% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4605.647% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1338.65% |
| Moolec Science SA | -51.78 Million USD | -1109.92% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3623620.703% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -363.748% |
| Design Therapeutics, Inc. | -66.86 Million USD | -837.16% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -669.651% |
| NeurAxis, Inc. | -14.62 Million USD | -4183.979% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1554.094% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1741.112% |
| Achilles Therapeutics plc | -69.66 Million USD | -799.453% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -527.125% |
| 180 Life Sciences Corp. | -19.93 Million USD | -3043.218% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 20925.78% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24706018.925% |
| Nutriband Inc. | -5.48 Million USD | -11323.302% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -522.267% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1189.123% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -712.811% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1744.581% |
| MoonLake Immunotherapeutics | -36 Million USD | -1640.216% |
| Palisade Bio, Inc. | -12.3 Million USD | -4994.341% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1387.523% |
| Beam Therapeutics Inc. | -132.52 Million USD | -372.812% |
| Neurogene Inc. | -36.31 Million USD | -1625.374% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -283.443% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1092.26% |
| Sesen Bio, Inc. | -19.88 Million USD | -3051.298% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -775.341% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4907.266% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -41.115% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -461.644% |
| Athira Pharma, Inc. | -117.67 Million USD | -432.501% |
| Vaccinex, Inc. | -20.25 Million USD | -2994.188% |
| HCW Biologics Inc. | -24.99 Million USD | -2406.99% |
| XOMA Corporation | -40.83 Million USD | -1434.628% |
| Nektar Therapeutics | -276.05 Million USD | -126.984% |
| Arvinas, Inc. | -367.3 Million USD | -70.597% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -930615.188% |
| Merus N.V. | -154.93 Million USD | -304.42% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -543.146% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1896.508% |
| Rezolute, Inc. | -68.45 Million USD | -815.298% |
| Clene Inc. | -49.5 Million USD | -1165.764% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3962.665% |
| BeyondSpring Inc. | -21.02 Million USD | -2880.139% |
| Synlogic, Inc. | -57.28 Million USD | -993.893% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -5165.137% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5687.955% |
| Peak Bio, Inc. | -1259.26 USD | -49759600.141% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1576.846% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5831.833% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -337.881% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -92.74% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -13465.896% |
| MannKind Corporation | -11.93 Million USD | -5148.819% |
| Ikena Oncology, Inc. | -68.16 Million USD | -819.232% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2881.699% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -574.253% |
| Gossamer Bio, Inc. | -179.81 Million USD | -248.468% |
| CohBar, Inc. | -11.96 Million USD | -5138.236% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2329.828% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1978.289% |
| Legend Biotech Corporation | -518.25 Million USD | -20.907% |
| Mural Oncology plc | -207.44 Million USD | -202.055% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -404.858% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3325.989% |
| Disc Medicine, Inc. | -76.42 Million USD | -719.851% |
| Champions Oncology, Inc. | -7.27 Million USD | -8511.93% |
| REGENXBIO Inc. | -263.49 Million USD | -137.806% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5804.076% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1219.027% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1549.674% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -525.584% |
| Vaxart, Inc. | -82.46 Million USD | -659.842% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 187839.204% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1569.052% |
| Cellectis S.A. | -101.05 Million USD | -520.038% |
| Longeveron Inc. | -21.41 Million USD | -2826.278% |
| Repare Therapeutics Inc. | -93.79 Million USD | -568.05% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -16.909% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -780.445% |
| Revolution Medicines, Inc. | -436.36 Million USD | -43.596% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -9435.9% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1932.845% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -803.76% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -867.997% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -6286.75% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 117.311% |
| Denali Therapeutics Inc. | -145.22 Million USD | -331.474% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -520967.075% |
| Veru Inc. | -93.15 Million USD | -572.663% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2218.266% |
| Cingulate Inc. | -23.53 Million USD | -2562.441% |
| Passage Bio, Inc. | -102.06 Million USD | -513.944% |
| Context Therapeutics Inc. | -23.96 Million USD | -2514.749% |
| Exicure, Inc. | -16.91 Million USD | -3604.647% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -231.682% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1559.263% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -9529.211% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -239.295% |
| Nuvalent, Inc. | -126.21 Million USD | -396.442% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5858.772% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -621.238% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1951.48% |
| OmniAb, Inc. | -50.61 Million USD | -1137.883% |
| Anew Medical, Inc. | 1.34 Million USD | 46648.723% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3805.291% |
| Lipocine Inc. | -16.35 Million USD | -3731.952% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -843.766% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -884.066% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1385.062% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1206.323% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -3059.72% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -15.719% |
| Ocugen, Inc. | -63.07 Million USD | -893.38% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -554.54% |
| Q32 Bio Inc. | -112.96 Million USD | -454.708% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3544.742% |
| Alumis Inc. Common Stock | -154.99 Million USD | -304.279% |
| Equillium, Inc. | -13.33 Million USD | -4598.943% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -938.008% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7744.478% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3223.943% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -960.567% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -447.123% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3309.542% |
| Dominari Holdings Inc. | -22.88 Million USD | -2638.414% |
| Edesa Biotech, Inc. | -8.37 Million USD | -7382.361% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2994.341% |
| Bio-Techne Corporation | 168.1 Million USD | 472.746% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -77.968% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 586.294% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -414.318% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1551.609% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -456.279% |
| Nkarta, Inc. | -117.5 Million USD | -433.275% |
| BioCardia, Inc. | -11.57 Million USD | -5315.297% |
| Iterum Therapeutics plc | -38.37 Million USD | -1533.015% |